$14.71
3.10% yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
IL0011595993
Symbol
INMD

Inmode Stock price

$14.71
+0.43 2.98% 1M
-1.26 7.89% 6M
-1.99 11.92% YTD
-2.11 12.54% 1Y
-8.43 36.43% 3Y
+0.44 3.05% 5Y
+7.93 116.80% 10Y
+7.93 116.80% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
-0.47 3.10%
ISIN
IL0011595993
Symbol
INMD
Sector

Key metrics

Basic
Market capitalization
$1.0b
Enterprise Value
$510.3m
Net debt
positive
Cash
$512.9m
Shares outstanding
67.9m
Valuation (TTM | estimate)
P/E
5.8 | 8.5
P/S
2.6 | 2.6
EV/Sales
1.3 | 1.3
EV/FCF
4.2
P/B
1.7
Financial Health
Equity Ratio
89.6%
Return on Equity
25.8%
ROCE
17.4%
ROIC
116.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$392.4m | $395.4m
EBITDA
$110.8m | $107.9m
EBIT
$110.1m | $106.1m
Net Income
$175.8m | $117.0m
Free Cash Flow
$122.0m
Growth (TTM | estimate)
Revenue
-15.8% | 0.2%
EBITDA
-36.1% | -4.7%
EBIT
-36.3% | -5.7%
Net Income
-2.9% | -35.5%
Free Cash Flow
-32.0%
Margin (TTM | estimate)
Gross
80.0%
EBITDA
28.2% | 27.3%
EBIT
28.1%
Net
44.8% | 29.6%
Free Cash Flow
31.1%
More
EPS
$2.5
FCF per Share
$1.8
Short interest
10.0%
Employees
599
Rev per Employee
$660.0k
Show more

Is Inmode a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Inmode Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Inmode forecast:

6x Buy
46%
7x Hold
54%

Analyst Opinions

13 Analysts have issued a Inmode forecast:

Buy
46%
Hold
54%

Financial data from Inmode

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
392 392
16% 16%
100%
- Direct Costs 78 78
1% 1%
20%
314 314
19% 19%
80%
- Selling and Administrative Expenses 191 191
5% 5%
49%
- Research and Development Expense 13 13
10% 10%
3%
111 111
36% 36%
28%
- Depreciation and Amortization 0.74 0.74
25% 25%
0%
EBIT (Operating Income) EBIT 110 110
36% 36%
28%
Net Profit 176 176
3% 3%
45%

In millions USD.

Don't miss a Thing! We will send you all news about Inmode directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inmode Stock News

Positive
Seeking Alpha
about 3 hours ago
InMode's fundamentals remain strong despite guidance cuts, macro headwinds, and governance disputes, making current negative sentiment appear overdone. Valuation is compelling at just 9.3x forward EPS and ~6% FCF yield, with a robust cash buffer and capital-light business model offering downside protection. Share buybacks are accelerating, shrinking share count and compounding per-share value, ...
Neutral
PRNewsWire
2 days ago
Conference call to be held on Wednesday, July 30, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, July 10, 2025 /PRNewswire/ -- InMode Ltd.
Neutral
PRNewsWire
about 2 months ago
YOKNEAM, Israel , May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public letter dated May 9, 2025.
More Inmode News

Company Profile

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Head office Israel
CEO Mr. Mizrahy
Employees 599
Founded 2008
Website inmodemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today